These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 25610864)
1. Inflammatory reaction in neurological diseases. Wang HC; Lu CH; Cheng KI; Chiang JC Biomed Res Int; 2014; 2014():408514. PubMed ID: 25610864 [No Abstract] [Full Text] [Related]
2. Inflammation and gliosis in neurological diseases--clinical implications. Członkowska A; Kurkowska-Jastrzębska I J Neuroimmunol; 2011 Feb; 231(1-2):78-85. PubMed ID: 20943275 [TBL] [Abstract][Full Text] [Related]
3. IL-4 in the brain: a cytokine to remember. Gadani SP; Cronk JC; Norris GT; Kipnis J J Immunol; 2012 Nov; 189(9):4213-9. PubMed ID: 23087426 [TBL] [Abstract][Full Text] [Related]
4. Multifaceted roles of neuroinflammation: the need to consider both sides of the coin. Kielian T J Neurochem; 2016 Jan; 136 Suppl 1():5-9. PubMed ID: 26806370 [No Abstract] [Full Text] [Related]
5. Neuroimmune crosstalk in the central nervous system and its significance for neurological diseases. Tian L; Ma L; Kaarela T; Li Z J Neuroinflammation; 2012 Jul; 9():155. PubMed ID: 22747919 [TBL] [Abstract][Full Text] [Related]
6. The enigma of neuroinflammation. Tandon PN Neurol India; 2017; 65(4):703-705. PubMed ID: 28681735 [No Abstract] [Full Text] [Related]
7. Inflammation in neurological disorders: a help or a hindrance? Wee Yong V Neuroscientist; 2010 Aug; 16(4):408-20. PubMed ID: 20817918 [TBL] [Abstract][Full Text] [Related]
10. Neurotrophic cross-talk between the nervous and immune systems: implications for neurological diseases. Kerschensteiner M; Stadelmann C; Dechant G; Wekerle H; Hohlfeld R Ann Neurol; 2003 Mar; 53(3):292-304. PubMed ID: 12601697 [TBL] [Abstract][Full Text] [Related]
11. Chemokines and chemokine receptors: multipurpose players in neuroinflammation. Ransohoff RM; Liu L; Cardona AE Int Rev Neurobiol; 2007; 82():187-204. PubMed ID: 17678962 [TBL] [Abstract][Full Text] [Related]
12. The significance of the "dying back" process in experimental and human neurological disease. Cavanagh JB Int Rev Exp Pathol; 1964; 3():219-67. PubMed ID: 5317971 [No Abstract] [Full Text] [Related]
13. [Immunobiological considerations of the pathology of inflammatory diseases of the nervous system]. Környey S Bratisl Lek Listy; 1969; 52(5):563-72. PubMed ID: 4391677 [No Abstract] [Full Text] [Related]
17. [Participation of nervous system influences on the cellular inflammatory reaction (preliminary report)]. Jansa P; Urbánek K Vnitr Lek; 1973 May; 19(5):448-51. PubMed ID: 4575751 [No Abstract] [Full Text] [Related]
18. The increasing importance of inflammation in neurological disease. Bone I Curr Opin Neurol; 2007 Jun; 20(3):331-3. PubMed ID: 17495629 [No Abstract] [Full Text] [Related]
19. mTOR: its role in the nervous system and involvement in neurologic disease. Child ND; Benarroch EE Neurology; 2014 Oct; 83(17):1562-72. PubMed ID: 25253752 [No Abstract] [Full Text] [Related]
20. Cortical, subcortical and spinal alterations in neuroimmunological diseases. Lassmann H J Neurol; 2007 May; 254 Suppl 2():II15-7. PubMed ID: 17503121 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]